Digoxin Injection bulk supplier for pharma manufacturers

Digoxin Injection 250 mcg/mL Suppliers & Bulk Manufacturers

Q: What is Digoxin Injection made from?

Digoxin Injection contains Digoxin, a cardiac glycoside derived from the Digitalis plant. It works by inhibiting the sodium-potassium ATPase pump in heart cells, increasing intracellular calcium, which strengthens heart contractions and slows the heart rate.

Q: What is Digoxin Injection trade name?

Trade names include Lanoxin Injection and various generic formulations available globally.

Q: What is brand name of Digoxin Injection?

Brand names include Lanoxin Injection, Digoxin Injection (Cipla, Sun Pharma, Lupin), and other regional generics.

Available Forms: Intravenous (IV) Injection

Available Strengths: 250 mcg/mL

Reference Brands: Lanoxin(US & EU)

Category: Critical Care

Digoxin is a key cardiac drug for heart failure and atrial fibrillation, available as oral tablets, oral solution, and 250 mcg/mL IV injection. Brands include Lanoxin and Digoxin Hameln. It is widely supplied to hospitals and clinics via pharma B2B procurement networks and institutional cardiac care supply chains.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Digoxin is a cardiac glycoside used in the treatment of heart failure and atrial fibrillation. It enhances myocardial contractility while controlling ventricular rate by inhibiting the sodium-potassium ATPase pump. Available in oral tablets (62.5, 125, and 250 mcg), oral solution (50 mcg/mL), and IV injection (250 mcg/mL), Digoxin is widely used in both acute and chronic cardiac care. In the US, Lanoxin and Pfizer’s generic injections are common, while EU brands include Lanoxin, Digoxin Hameln, and Meda. Hospitals, cardiology centers, and clinics procure Digoxin regularly through pharma B2B platforms and hospital group purchasing organizations.

Digoxin Injection — third party manufacturing & bulk supply

Digoxin Injection 250 mcg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Digoxin Injection is supplied as Intravenous (IV) Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Digoxin Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Digoxin Injection →

Back to Listing

Frequently Asked Questions

Digoxin Injection contains Digoxin, a cardiac glycoside derived from the Digitalis plant. It works by inhibiting the sodium-potassium ATPase pump in heart cells, increasing intracellular calcium, which strengthens heart contractions and slows the heart rate.

Trade names include Lanoxin Injection and various generic formulations available globally.

Digoxin Injection is manufactured by multiple pharmaceutical companies, including Pfizer, Cipla, and Sun Pharma.

The generic name is Digoxin.

Brand names include Lanoxin Injection, Digoxin Injection (Cipla, Sun Pharma, Lupin), and other regional generics.

Digoxin Injection is manufactured in the USA, Europe, India, and other regions by multiple approved pharmaceutical companies under regulatory standards.